Evaluation of the Relationship between Hemoglobin A1c and Diabetic Retinopathy in Patients with Type Ⅱ Diabetes at Tishreen University Hospital- Latakia- Syria

International Journal of Medical Science

© 2024 by SSRG - IJMS Journal

Volume 11 Issue 1

Year of Publication : 2024

Authors : Faisal Redwan

10.14445/23939117/IJMS-V11I1P107

How to Cite?

Faisal Redwan, "Evaluation of the Relationship between Hemoglobin A1c and Diabetic Retinopathy in Patients with Type Ⅱ Diabetes at Tishreen University Hospital- Latakia- Syria," SSRG International Journal of Medical Science, vol. 11,  no. 1, pp. 36-39, 2024. Crossref, https://doi.org/10.14445/23939117/IJMS-V11I1P107

Abstract:

Background: Diabetic Retinopathy (DR) may be a common and specific microvascular complication of diabetes leading to blindness in working-aged people. Glycated hemoglobin (HbA1c) has an important role in diagnosing diabetes, but the assessment of its role in Diabetic Retinopathy (DR) is still unclear. Objective: This study aims to determine the prevalence of Diabetic retinopathy in Tishreen University Hospital- Latakia-Syria and evaluate its association with HbA1c. Methods: A cross-sectional survey was conducted on patients in the ophthalmic clinic of Tishreen University Hospital from May 2020 to December 2021. Results: The total number of diabetic patients in the current study was 222, 190 of them with type Ⅱ and 32 with type Ⅰ. Of 190 patients, 99 were males and 91 were females. The mean age of them was 64.46± 8.29 years, with a range (of 27-82) years. Of 222 patients, the prevalence of DR was 72.97%. As for the relationship between HbA1c levels and DR, a statistically significant association was recorded between them (p<0.001). Conclusion: It is important to control blood glucose and maintain HbA1c levels within the normal range. We recommend early diagnosis, treatment and prevention measures.

Keywords:

Diabetic Retinopathy, DR, HbA1c, Glycated hemoglobin, Diabetes, Syria.

References:

[1] Janusz Pieczyński, and Andrzej Grzybowski, “Review of Diabetic Retinopathy Screening Methods Programs Adopted in Different Parts of the World. Updated,” European Ophthalmic Review, vol. 9, no. 1, pp. 49-55, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Han Ul Kim, Sung Pyo Park, and Yong-Kyu Kim, “Long-Term HbA1c Variability and the Development and Progression of Diabetic Retinopathy in Subjects with Type 2 Diabetes,” Scientifc Reports, vol. 11, pp. 1-10, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[3] American Diabetes Association, “Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, vol. 33, no. 1, pp. S62-S69, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Chirag Singh et al., “Association of HbA1c Levels with Diabetic Retinopathy,” Indian Journal of Clinical and Experimental Ophthalmology, vol. 7, no. 2, pp. 339-345, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Alvin C. Powers, Kevin D. Niswender, and Carmella Evans-Molina, “Diabetes Mellitus: Diagnosis, Classification, and Patho Physiology,” Harrison’s Principles of Internal Medicine, Mcgraw-Hill Medical, pp. 2580-2558, 2020.
[Google Scholar] [Publisher Link]
[6] Bo Zhang et al., “The Value of Glycosylated Hemoglobin in the Diagnosis of Diabetic Retinopathy: A Systematic Review and Meta-Analysis,” BMC Endocrine Disorders, vol. 21, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Marcus Lind et al., “HbA1c Level as a Risk Factor for Retinopathy and Nephropathy in Children and Adults with Type 1 Diabetes: Swedish Population Based Cohort Study,” The BMJ, vol. 366, pp. 1-9, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[8] D.M. Nathan et al., “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus,” The New England Journal of Medicine, vol. 329, pp. 977-986, 1993.
[CrossRef] [Google Scholar] [Publisher Link]
[9] Timothy S. Kern, David A. Antonetti, and Lois E.H. Smith, “Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research,” Ophthalmic Research, vol. 62, no. 4, pp. 196-202, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[10] D-10 Hemoglobin A1c Program L20012105 Instruction Manual. [Online]. Available: https://www.mdkhospital.com/documents/Hemoglobin%20A1c%20D10.pdf
[11] Boditech Med Inc, ichroma™ HbA1c, Document No. : INS-AA-EN.
[12] Pragati Garg et al., “Correlative Study of Diabetic Retinopathy with HbA1c and Microalbuminuria,” International Journal of Ophthalmic Research, vol. 4, no. 2, pp. 282-286, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[13] UK Prospective Diabetes Study Group, “Intensive Blood Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS33),” The Lancet, vol. 352, no. 9131, pp. 837-853, 1998.
[CrossRef] [Google Scholar] [Publisher Link]
[14] S. Lokesh, and S. Shivaswamy, “Study of HbA1C Levels in Patients with Type 2 Diabetes Mellitus in Relation to Diabetic Retinopathy in Indian Population,” International Journal of Advances in Medicine, vol. 5, no. 6, pp. 1-10, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[15] M. Long, C. Wang, and D. Liu, “Glycated Hemoglobin A1C and Vitamin D and Their Association with Diabetic Retinopathy Severity,” Nutrition & Diabetes, vol. 7, no. 6, pp. 1-7, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Saad Hajar et al., “Prevalence and Causes of Blindness and Diabetic Retinopathy in Southern Saudi Arabia,” Saudi Medical Journal, vol. 36, no. 4, pp. 449-455, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Wojciech Matuszewski et al., “Prevalence of Diabetic Retinopathy in Type 1 and Type 2 Diabetes Mellitus Patients in North-East Poland,” Medicina, vol. 56, no. 4, pp. 1-9, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[18] J.H. Kempen et al., “The Prevalence of Diabetic Retinopathy among Adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 552-563, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Robyn J. Tapp et al., “The Prevalence of and Factors Associated with Diabetic Retinopathy in the Australian Population,” Diabetes Care, vol. 26, no. 6, pp. 1731-1737, 2003.
[CrossRef] [Google Scholar] [Publisher Link]
[20] Pedro Romero-Aroca et al., “Differences in Incidence of Diabetic Retinopathy between Type 1 and 2 Diabetes Mellitus: A Nine-Year Follow-Up Study,” British Journal of Ophthalmology, vol. 101, no. 10, pp. 1346-1351, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Sarah Polack et al., “Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Chiapas, Mexico,” Ophthalmology, vol. 119, no. 5, pp. 1033-1040, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Mansur M. Rabiu et al., “Prevalence of Blindness and Diabetic Retinopathy in Northern Jordan,” European Journal of Ophthalmology, vol. 25, no. 4, pp. 320-327, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[23] Stuart A. Ross et al., “Diabetic Retinopathy in Native and Nonnative Canadians,” Journal of Diabetes Research, vol. 2007, pp. 1-7, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[24] Masoud R. Manaviat, Mohammad Afkhami, and Mohammad R. Shoja, “Retinopathy and Microalbuminuria in Type II Diabetic Patients,” BMC Ophthalmology, vol. 4, pp. 1-4, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[25] Haibing Chen et al., “A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients,” PLoS ONE, vol. 7, no. 5, pp. 1-6, 2012.
[CrossRef] [Google Scholar] [Publisher Link]